Individualized rTMS Based on fNIRS to Spasticity

Sponsor
First Affiliated Hospital Xi'an Jiaotong University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05318586
Collaborator
(none)
20
1
2
20.7
1

Study Details

Study Description

Brief Summary

Stroke is of high morbidity and mortality, and surviving patients are often unable to take care of themselves because of severe motor dysfunction. The brain has plasticity, and makes adaptive changes after stroke, resulting in the reorganization and compensation of neural networks. However, the muscle tone of some patients will significantly increase during the recovery process, which affects the rehabilitation effect. Neuromodulation techniques such as repetitive transcranial magnetic stimulation (rTMS) have been widely used to promote brain network remodeling after stroke. The investigators attempted to evaluate the motor brain network characteristics of spastic patients by fNIRS, and used the most active brain regions as rTMS stimulation regions to evaluate the improvement effect of this individualized treatment on post-stroke spasticity.

Condition or Disease Intervention/Treatment Phase
  • Procedure: individual rTMS based on fNIRS
  • Procedure: Traditional rTMS strategy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effect of Individualized rTMS Based on fNIRS on the Upper Limb Spasticity After Stroke
Actual Study Start Date :
Apr 10, 2022
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Individualized rTMS based on fNIRS

Low-frequency rTMS will be given to the most active brain regions assessed by fNIRS.

Procedure: individual rTMS based on fNIRS
The rTMS parameters will be set according to fNIRS results.

Active Comparator: Traditional rTMS strategy

The control group will always be given low-frequency rTMS to contralesional M1

Procedure: Traditional rTMS strategy
The low-frequency rTMS to contralesional M1 will always be used.

Outcome Measures

Primary Outcome Measures

  1. modified Ashworth scale [1 month]

    The range is 0-Ⅳ level, the higher the level, the higher the spasticity.

Secondary Outcome Measures

  1. Fugl-Meyer Assessment of upper limb motor function [1 month]

    The score range is 0-66 points, the higher the score, the better the motor function of upper limb.

  2. Barthel index [1 month]

    The score range is 0-100 points, the higher the score, the better the activities of daily living.

  3. average weighted clustering coefficient [1 month]

    This is a brain network indicator based on graph theory. It is a measure of the local separation of the graph. The higher the average weighted clustering coefficient, the higher the degree of segregation of the brain network.

  4. global efficiency [1 month]

    This is a brain network indicator based on graph theory. It is a measure of the local integration of the graph. The higher the global efficiency, the stronger the ability of the network to transmit information.

  5. inter-density [1 month]

    It is a brain network indicator based on graph theory and is defined as the ratio of the actual number of connections among all possible connections between bilateral hemispheres.

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 79 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Aged 40-79 years;

  • Patients with first-onset stroke within 1 to 3 months after onset;

  • Consciousness, sitting balance level 1 or above, can cooperate with fNIRS assessment;

  • The patient or its authorized agent signs the informed consent form.

Exclusion Criteria:
  • Previous seizures;

  • Suffered from mental illness such as depression, anxiety, mania, and schizophrenia before the stroke onset;

  • Patients with metal on the head, cochlear implants, intracranial infections, etc. who are not suitable for rTMS.

Contacts and Locations

Locations

Site City State Country Postal Code
1 First Affiliated Hospital of Xi'an Jiaotong University Xi'an Shaanxi China 710000

Sponsors and Collaborators

  • First Affiliated Hospital Xi'an Jiaotong University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
First Affiliated Hospital Xi'an Jiaotong University
ClinicalTrials.gov Identifier:
NCT05318586
Other Study ID Numbers:
  • 2022JQ-982
First Posted:
Apr 8, 2022
Last Update Posted:
Apr 20, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by First Affiliated Hospital Xi'an Jiaotong University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 20, 2022